208 related articles for article (PubMed ID: 15524164)
1. The endothelium in health and disease: a discussion of the contribution of non-nitric oxide endothelium-derived vasoactive mediators to vascular homeostasis in normal vessels and in type II diabetes.
Triggle CR; Ding H; Anderson TJ; Pannirselvam M
Mol Cell Biochem; 2004 Aug; 263(1-2):21-7. PubMed ID: 15524164
[TBL] [Abstract][Full Text] [Related]
2. The endothelium in health and disease: A discussion of the contribution of non-nitric oxide endothelium-derived vasoactive mediators to vascular homeostasis in normal vessels and in type II diabetes.
Triggle CR; Ding H; Anderson TJ; Pannirselvam M
Mol Cell Biochem; 2004 Aug; 263(1):21-7. PubMed ID: 27520662
[TBL] [Abstract][Full Text] [Related]
3. [Endothelium-derived hyperpolarizing factor].
Brăiloiu C; Beşchea-Chiriac C; Chiriac M
Rev Med Chir Soc Med Nat Iasi; 1998; 102(3-4):49-55. PubMed ID: 10756843
[TBL] [Abstract][Full Text] [Related]
4. [Endothelium-derived hyperpolarizing factor (EDHF): potential involvement in the physiology and pathology of blood vessels].
Kozłowska H; Baranowska M; Gromotowicz A; Malinowska B
Postepy Hig Med Dosw (Online); 2007 Oct; 61():555-64. PubMed ID: 17971759
[TBL] [Abstract][Full Text] [Related]
5. The endothelium in health and disease--a target for therapeutic intervention.
Triggle CR; Hollenberg M; Anderson TJ; Ding H; Jiang Y; Ceroni L; Wiehler WB; Ng ES; Ellis A; Andrews K; McGuire JJ; Pannirselvam M
J Smooth Muscle Res; 2003 Dec; 39(6):249-67. PubMed ID: 15048017
[TBL] [Abstract][Full Text] [Related]
6. Contribution of endothelium-derived hyperpolarizing factors to the regulation of vascular tone in humans.
Bellien J; Thuillez C; Joannides R
Fundam Clin Pharmacol; 2008 Aug; 22(4):363-77. PubMed ID: 18705747
[TBL] [Abstract][Full Text] [Related]
7. Role of endothelium-derived hyperpolarizing factor in endothelial dysfunction during diabetes.
Fitzgerald SM; Kemp-Harper BK; Tare M; Parkington HC
Clin Exp Pharmacol Physiol; 2005; 32(5-6):482-7. PubMed ID: 15854163
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in animals and humans.
Shimokawa H; Morikawa K
J Mol Cell Cardiol; 2005 Nov; 39(5):725-32. PubMed ID: 16122755
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen peroxide as an endothelium-derived hyperpolarizing factor.
Shimokawa H
Pflugers Arch; 2010 May; 459(6):915-22. PubMed ID: 20140449
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
11. Effects of angiotensin II receptor antagonist on impaired endothelium-dependent and endothelium-independent relaxations in type II diabetic rats.
Oniki H; Fujii K; Kansui Y; Goto K; Iida M
J Hypertens; 2006 Feb; 24(2):331-8. PubMed ID: 16508581
[TBL] [Abstract][Full Text] [Related]
12. Endothelium-derived hyperpolarizing factor: is there a novel chemical mediator?
Triggle CR; Ding H
Clin Exp Pharmacol Physiol; 2002 Mar; 29(3):153-60. PubMed ID: 11906476
[TBL] [Abstract][Full Text] [Related]
13. Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease.
Luksha L; Agewall S; Kublickiene K
Atherosclerosis; 2009 Feb; 202(2):330-44. PubMed ID: 18656197
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characteristics of endothelium-derived hyperpolarizing factor-mediated relaxation of small mesenteric arteries from db/db mice.
Pannirselvam M; Ding H; Anderson TJ; Triggle CR
Eur J Pharmacol; 2006 Dec; 551(1-3):98-107. PubMed ID: 17027963
[TBL] [Abstract][Full Text] [Related]
15. [Role of nitric oxide and other endothelium-derived factors].
Stankevicius E; Kevelaitis E; Vainorius E; Simonsen U
Medicina (Kaunas); 2003; 39(4):333-41. PubMed ID: 12738901
[TBL] [Abstract][Full Text] [Related]
16. Interactions between endothelium-derived relaxing factors in the rat hepatic artery: focus on regulation of EDHF.
Zygmunt PM; Plane F; Paulsson M; Garland CJ; Högestätt ED
Br J Pharmacol; 1998 Jul; 124(5):992-1000. PubMed ID: 9692786
[TBL] [Abstract][Full Text] [Related]
17. Effects of endothelium-derived hyperpolarizing factor and nitric oxide on endothelial function in femoral resistance arteries of spontaneously hypertensive rats.
Mori Y; Ohyanagi M; Koida S; Ueda A; Ishiko K; Iwasaki T
Hypertens Res; 2006 Mar; 29(3):187-95. PubMed ID: 16755154
[TBL] [Abstract][Full Text] [Related]
18. Caveolae, caveolin and control of vascular tone: nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF) regulation.
Rath G; Dessy C; Feron O
J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():105-9. PubMed ID: 20083858
[TBL] [Abstract][Full Text] [Related]
19. Eicosapentaenoic acid improves imbalance between vasodilator and vasoconstrictor actions of endothelium-derived factors in mesenteric arteries from rats at chronic stage of type 2 diabetes.
Matsumoto T; Nakayama N; Ishida K; Kobayashi T; Kamata K
J Pharmacol Exp Ther; 2009 Apr; 329(1):324-34. PubMed ID: 19164460
[TBL] [Abstract][Full Text] [Related]
20. Diverse mechanisms of endothelium-derived hyperpolarizing factor-mediated dilatation in small myometrial arteries in normal human pregnancy and preeclampsia.
Luksha L; Luksha N; Kublickas M; Nisell H; Kublickiene K
Biol Reprod; 2010 Nov; 83(5):728-35. PubMed ID: 20610807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
